Maja-Lisa Clausen
Maja-Lisa Clausen
BBH
Verified email at regionh.dk
TitleCited byYear
Quality of life and disease severity in patients with atopic dermatitis
JG Holm, T Agner, ML Clausen, SF Thomsen
Journal of the European Academy of Dermatology and Venereology 30 (10), 1760 …, 2016
502016
Human β‐defensin‐2 as a marker for disease severity and skin barrier properties in atopic dermatitis
ML Clausen, JM Jungersted, PS Andersen, HC Slotved, KA Krogfelt, ...
British Journal of Dermatology 169 (3), 587-593, 2013
412013
Staphylococcus aureus colonization in atopic eczema and its association with filaggrin gene mutations
ML Clausen, SM Edslev, PS Andersen, K Clemmensen, KA Krogfelt, ...
British Journal of Dermatology 177 (5), 1394-1400, 2017
362017
Current knowledge on biomarkers for contact sensitization and allergic contact dermatitis
SA Koppes, KA Engebretsen, T Agner, I Angelova‐Fischer, T Berents, ...
Contact Dermatitis 77 (1), 1-16, 2017
322017
Association of disease severity with skin microbiome and filaggrin gene mutations in adult atopic dermatitis
ML Clausen, T Agner, B Lilje, SM Edslev, TB Johannesen, PS Andersen
JAMA dermatology 154 (3), 293-300, 2018
282018
Tape stripping technique for stratum corneum protein analysis
ML Clausen, HC Slotved, KA Krogfelt, T Agner
Scientific reports 6, 19918, 2016
222016
Effect of glove occlusion on the skin barrier
D Tiedemann, ML Clausen, SM John, I Angelova‐Fischer, S Kezic, ...
Contact dermatitis 74 (1), 2-10, 2016
212016
In vivo expression of antimicrobial peptides in atopic dermatitis
ML Clausen, HC Slotved, KA Krogfelt, PS Andersen, T Agner
Experimental dermatology 25 (1), 3-9, 2016
212016
Facial recognition and laser surface scan: a pilot study
N Lynnerup, ML Clausen, AM Kristoffersen, H Steglich-Arnholm
Forensic science, medicine, and pathology 5 (3), 167-173, 2009
172009
Antimicrobial peptides, infections and the skin barrier
ML Clausen, T Agner
Skin Barrier Function 49, 38-46, 2016
132016
Measurements of AMPs in stratum corneum of atopic dermatitis and healthy skin–tape stripping technique
ML Clausen, HC Slotved, KA Krogfelt, T Agner
Scientific reports 8 (1), 1-8, 2018
102018
The influence of probiotics for preterm neonates on the incidence of atopic dermatitis—results from a historically controlled cohort study
JA Damm, B Smith, G Greisen, KA Krogfelt, ML Clausen, T Agner
Archives of dermatological research 309 (4), 259-264, 2017
92017
Skin barrier dysfunction and the atopic march
ML Clausen, T Agner, SF Thomsen
Current Treatment Options in Allergy 2 (3), 218-227, 2015
82015
Genomic analysis reveals different mechanisms of fusidic acid resistance in Staphylococcus aureus from Danish atopic dermatitis patients
SM Edslev, ML Clausen, T Agner, M Stegger, PS Andersen
Journal of Antimicrobial Chemotherapy 73 (4), 856-861, 2018
52018
Determinants of disease severity among patients with atopic dermatitis: association with components of the atopic march
JG Holm, T Agner, ML Clausen, SF Thomsen
Archives of dermatological research 311 (3), 173-182, 2019
12019
Use of complementary and alternative therapies in outpatients with atopic dermatitis from a dermatological university department
JG Holm, ML Clausen, T Agner, SF Thomsen
Dermatology 235 (3), 189-195, 2019
12019
Temporal variation of Staphylococcus aureus clonal complexes in atopic dermatitis: a follow‐up study
ML Clausen, SM Edslev, LB Nørreslet, JA Sørensen, PS Andersen, ...
British Journal of Dermatology 180 (1), 181-186, 2019
12019
The Skin Microbiome in Atopic Dermatitis—a Potential Treatment Target?
CM Olesen, ML Clausen, PS Andersen, T Agner
Current Dermatology Reports 7 (4), 199-208, 2018
12018
The danish atopy database (DAD): rationale and methods
S Francis Thomsen, J Mutanu Jungersted, ML Clausen, T Agner
The Open Allergy Journal 5 (1), 2012
12012
The inhabitants of our skin
ML Clausen, T Agner
British Journal of Dermatology 181 (4), 661-662, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–20